Acting for Structure Therapeutics Inc. (NASDAQ: GPCR) in its US$547 million public offering

Cayman Islands counsel to Structure Therapeutics Inc., a clinical-stage global biopharmaceutical company, in its upsized public offering in June 2024. Lucy Anderson led our team.